Microvascular and astrocytic responses to repeated magnetic resonance-guided focused ultrasound.
Authors: Rigollet S, Delphin A, Chalet L, Ador T, Dumont E, Lemasson B, Christen T, Pichon C, Delalande A, Stupar V, Barbier EL
Focused ultrasound (FUS), in combination with microbubbles, enables the transient and localized opening of the blood-brain barrier (BBB) for targeted drug delivery. While this technique has shown promise in preclinical models, the safety and neurovascular consequences of repeated BBB permeabilization remain incompletely understood. In this study, we performed a longitudinal assessment of vascular, microstructural, and glial responses following repeated FUS-mediated BBB opening in healthy rats using magnetic resonance (MR)-guided targeting and MR vascular fingerprinting. FUS sessions were conducted on a weekly or twice-weekly basis over a period of four weeks, employing two distinct acoustic pressures, 390 kPa and 440 kPa, respectively. The BBB opening was reproducible across sessions, with stable contrast enhancement observed with DCE-MRI and a homogeneous cumulative open BBB volume. No significant hemorrhages or edema were detected; however, transient cerebral blood flow reductions of approximately 15-20 % were observed following each session. After eight FUS sessions at 440 kPa, subtle vascular remodeling was observed, including increased vessel radius and reduced tissue oxygen saturation. This finding was confirmed by both MRI and histological analysis. Astrocytic activation, as determined by GFAP immunostaining, was minimal after a single or weekly FUS exposure but became significant with biweekly treatments, indicating a cumulative neuroimmune response. These results support the feasibility of weekly FUS-induced BBB opening at moderate acoustic pressures. However, they also underscore the importance of protocol optimization to prevent glial and vascular stress in long-term therapeutic applications.
Introduction
Purpose
Drug delivery with BBB opening
Study Objective
To investigate the microvascular and astrocytic responses to repeated magnetic resonance-guided focused ultrasound.
Animal model / Human subject
Forty-three Wistar Han rats from Janvier Labs
Disease model
healthy
MRI or image guidance method
Magnetic resonance-guided focused ultrasound (MRgFUS): a noninvasive acoustic energy-based experimental modality that delivers focused ultrasound to targeted brain regions under MRI guidance; used repeatedly to perturb microvascular and astrocytic physiology (specific sonication parameters not provided in the title).
Targeted brain region(s)
Striatum
Target coordinates
not reported
Cargo name and characteristics
perfluorobutane gas
Route of administration
intravenous
Outcomes and Safety
Summary of Outcomes
Repeated MR-guided focused ultrasound produced microvascular alterations including increased permeability and blood–brain barrier disruption, accompanied by astrocytic activation (reactive gliosis).
Duration of biological effect
Rats were euthanized
Safety-related matter
No safety concerns or adverse effects are mentioned in the provided text.
Brain Region
Ultrasound Parameters
Ultrasound instrument
MRgFUS system (Image Guided Therapy, Pessac, France)
FUS Frequency
1.5 MHz
FUS Intensity
Not reported in provided text
FUS Pressure
40 kPa
FUS Mode
Continuous
Pulse duration
not reported
Duration of a single FUS session
34 s.
Focal Characteristics
radius of curvature: 20.01 mm
Treatment frequency
multiple sessions
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search